13F
中

NAII NATURAL ALTERNATIVES INTL

2026Q1 · CUSIP 638842302 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
22
Δ holders QoQ
-2
Breadth percentile
n/a
Whale holders
11
Δ whales
+1
Inst. holding value
$6M
New positions
4
Closed positions
6
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+1 · h=27 2018Q2: Δ-2 · h=25 2018Q3: Δ+1 · h=26 2018Q4: Δ+0 · h=26 2019Q1: Δ+0 · h=26 2019Q2: Δ+1 · h=27 2019Q3: Δ+2 · h=29 2019Q4: Δ-1 · h=28 2020Q1: Δ-1 · h=27 2020Q2: Δ+1 · h=28 2020Q3: Δ-4 · h=24 2020Q4: Δ-2 · h=22 2021Q1: Δ+5 · h=27 2021Q2: Δ+0 · h=27 2021Q3: Δ+4 · h=31 2021Q4: Δ-5 · h=26 2022Q1: Δ-2 · h=24 2022Q2: Δ-1 · h=23 2022Q3: Δ+0 · h=23 2022Q4: Δ+1 · h=24 2023Q1: Δ-1 · h=23 2023Q2: Δ+3 · h=26 2023Q3: Δ-1 · h=25 2023Q4: Δ+2 · h=27 2024Q1: Δ-3 · h=24 2024Q2: Δ+4 · h=28 2024Q3: Δ-5 · h=23 2024Q4: Δ+3 · h=26 2025Q1: Δ-3 · h=23 2025Q2: Δ+0 · h=23 2025Q3: Δ-2 · h=21 2025Q4: Δ+3 · h=24 2026Q1: Δ-2 · h=22 2018Q1: holders=27 2018Q2: holders=25 2018Q3: holders=26 2018Q4: holders=26 2019Q1: holders=26 2019Q2: holders=27 2019Q3: holders=29 2019Q4: holders=28 2020Q1: holders=27 2020Q2: holders=28 2020Q3: holders=24 2020Q4: holders=22 2021Q1: holders=27 2021Q2: holders=27 2021Q3: holders=31 2021Q4: holders=26 2022Q1: holders=24 2022Q2: holders=23 2022Q3: holders=23 2022Q4: holders=24 2023Q1: holders=23 2023Q2: holders=26 2023Q3: holders=25 2023Q4: holders=27 2024Q1: holders=24 2024Q2: holders=28 2024Q3: holders=23 2024Q4: holders=26 2025Q1: holders=23 2025Q2: holders=23 2025Q3: holders=21 2025Q4: holders=24 2026Q1: holders=22 -5 -2.5 +0 +2.5 +5 182633 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.40
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+13.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $53M 2022-09-30: $43M 2022-12-31: $42M 2023-03-31: $33M 2023-06-30: $36M 2023-09-30: $34M 2023-12-31: $25M 2024-03-31: $25M 2024-06-30: $29M 2024-09-30: $33M 2024-12-31: $34M 2025-03-31: $29M 2025-06-30: $34M 2025-09-30: $38M 2025-12-31: $35M 2026-03-31: $35M 2022-06-30: EPS 0.52 2022-09-30: EPS 0.18 2022-12-31: EPS 0.31 2023-03-31: EPS -0.41 2023-06-30: EPS 0.35 2023-09-30: EPS -0.12 2023-12-31: EPS -0.52 2024-03-31: EPS -0.27 2024-06-30: EPS -0.32 2024-09-30: EPS -0.33 2024-12-31: EPS -0.37 2025-03-31: EPS -0.37 2025-06-30: EPS -1.21 2025-09-30: EPS -0.05 2025-12-31: EPS -0.42 2026-03-31: EPS -0.72 0M 26M 53M $M -1.33 -0.38 0.57 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 16 2023-03-31: PE 12.82023-06-30: PE 16.22023-09-30: PE 47.2 12 31 50 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)